Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Miller

Thoracic Surgery (Cardiothoracic Vascular Surgery) Marietta, GA Medical Doctor

NPI 1831288430 CMS profile 355511

61 Whitcher St Ne, Suite 4120, Marietta, GA 30060

Open in the dashboard

General payments

$236,684

313 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Miller of Marietta, GA is reported in the CMS Open Payments database as having received $236,684 across 313 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,209 26
2024 General $34,911 42
2023 General $66,835 63
2022 General $70,604 80
2021 General $13,396 17
2020 General $21,130 33
2019 General $11,601 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Miller
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Daniel Miller were reported at $18,209. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Daniel Miller Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $11,601 $886 $178–$3,167 $163
2020 $21,130 $341 $108–$1,605 $114
2021 $13,396 $453 $125–$1,886 $132
2022 $70,604 $695 $180–$2,566 $149
2023 $66,835 $745 $205–$2,662 $160
2024 $34,911 $799 $214–$2,967 $164
2025 $18,209 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ethicon Inc. $75,215 55 payments
  2. Atricure, Inc. $49,486 54 payments
  3. Medical Device Business Services, Inc. $40,336 37 payments
  4. Acumed LLC $39,085 40 payments
  5. Pacira Pharmaceuticals Incorporated $10,641 16 payments
  6. TELA Bio, Inc. $8,516 13 payments
  7. Ethicon US, LLC $8,135 22 payments
  8. Medela AG $1,500 1 payment
  9. Davol Inc. $635 6 payments
  10. AstraZeneca Pharmaceuticals LP $525 13 payments
  11. Other $2,610 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $154,349 42 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $38,100 10 payments
  3. Travel and Lodging $33,683 91 payments
  4. Food and Beverage $10,553 170 payments
Products named General payments · program years 2019–2025
  1. ECHELON ENDOPATH $48,587 21 payments
  2. Echelon Flex Surgery-Bariatric $47,642 31 payments
  3. Echelon Flex Endo-Mechanical $45,694 20 payments
  4. Harmonic $41,267 18 payments
  5. AtriCure cryoICE cryoSPHERE Cryoablation System $34,613 35 payments
  6. BioBridge Chest $25,596 24 payments
  7. RibLoc $15,858 16 payments
  8. SYNERGY ABLATION SYSTEM $11,468 5 payments
  9. EXPAREL $10,141 15 payments
  10. BioBridge Chest $10,000 7 payments
  11. Other $52,269 169 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$54,308

Medicare's payments for the services billed

Medicare patients

116

Average age 71

Services billed

275

56 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 53%
Arthritis 48%
Ischemic heart disease 47%
COPD 47%
Diabetes 33%
Heart failure 26%
Atrial fibrillation 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KEYTRUDA
  • Merck Sharp & Dohme Corporation $237
$237 — —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

313 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record